Skip to main content
. 2020 Jul 21;26(27):3975–3988. doi: 10.3748/wjg.v26.i27.3975

Table 5.

Observed adverse events according to common terminology criteria for adverse events grading, n (%)

Adverse event TACE/HAIC + S-1, n = 55 TACE/HAIC, n = 60 P value
Liver injury 0.243
Grades 1-2 28 (50.9) 23 (38.3)
Grades 3-4 27 (49.1) 37 (61.7)
Vomiting 0.478
Grades 1-2 23 (41.8) 29 (48.3)
Grades 3-4 1 (1.8) 0 (0)
Abdominal pain 0.820
Grades 1-2 37 (67.3) 37 (61.7)
Grades 3-4 10 (18.2) 13 (21.7)
Fever 0.277
Grades 1-2 45 (81.8) 44 (73.3)
Grades 3-4 0 (0) 0 (0)
Leukopenia 0.465
Grades 1 2 (3.6) 4 (6.7)
Grades 2-4 0 (0) 0 (0)
Thrombocytopenia 0.793
Grade 1 9 (16.4) 11 (18.3)
Grade 2 7 (12.7) 7 (11.7)
Grade 3 0 (0) 1 (1.7)
Grade 4 0 (0) 0 (0)
Anemia 0.220
Grade 1 7 (12.7) 15 (25.0)
Grade 2 2 (3.6) 5 (8.3)
Grade 3 1 (1.8) 1 (1.7)
Grade 4 0 (0) 0 (0)

HAIC: Hepatic arterial infusion chemotherapy; TACE: Transarterial chemoembolization.